Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 72576 - 72600 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	RDH5	5959	downregulated	Silicon Dioxide analog results in decreased expression of RDH5 mRNA	12q13.2	A24195
Silicon dioxide	Approved	RDH8	50700	upregulated	Silicon Dioxide analog results in increased expression of RDH8 mRNA	19p13.2	A24195
Silicon dioxide	Approved	RDM1	201299	downregulated	Silicon Dioxide analog results in decreased expression of RDM1 mRNA	17q12	A24195
Silicon dioxide	Approved	RECK	8434	downregulated	Silicon Dioxide analog results in decreased expression of RECK mRNA	9p13.3	A24195
Silicon dioxide	Approved	RELB	5971	upregulated	Silicon Dioxide analog results in increased expression of RELB mRNA	19q13.32	A24194 A24195
Silicon dioxide	Approved	RELB	5971	upregulated	Silicon Dioxide results in increased expression of RELB mRNA	19q13.32	A24196
Silicon dioxide	Approved	RELN	5649	upregulated	Silicon Dioxide analog results in increased expression of RELN mRNA	7q22.1	A24194
Silicon dioxide	Approved	RERG	85004	downregulated	Silicon Dioxide analog results in decreased expression of RERG mRNA	12p12.3	A24195
Silicon dioxide	Approved	RERGL	79785	downregulated	Silicon Dioxide analog results in decreased expression of RERGL mRNA	12p12.3	A24194
Silicon dioxide	Approved	RFTN2	130132	upregulated	Silicon Dioxide analog results in increased expression of RFTN2 mRNA	2q33.1	A24195
Silicon dioxide	Approved	RFX2	5990	downregulated	Silicon Dioxide analog results in decreased expression of RFX2 mRNA	19p13.3	A24195
Silicon dioxide	Approved	RGCC	28984	downregulated	Silicon Dioxide analog results in decreased expression of RGCC mRNA	13q14.11	A24195
Silicon dioxide	Approved	RGMA	56963	downregulated	Silicon Dioxide analog results in decreased expression of RGMA mRNA	15q26.1	A24195
Silicon dioxide	Approved	RGN	9104	upregulated	Silicon Dioxide analog results in increased expression of RGN mRNA	Xp11.3	A24194
Silicon dioxide	Approved	RGS11	8786	upregulated	Silicon Dioxide analog results in increased expression of RGS11 mRNA	16p13.3	A24195
Silicon dioxide	Approved	RGS12	6002	upregulated	Silicon Dioxide results in increased expression of RGS12 mRNA	4p16.3	A24196
Silicon dioxide	Approved	RGS16	6004	upregulated	Silicon Dioxide analog results in increased expression of RGS16 mRNA	1q25.3	A24194 A24195
Silicon dioxide	Approved	RGS17	26575	upregulated	Silicon Dioxide results in increased expression of RGS17 mRNA	6q25.2	A24196
Silicon dioxide	Approved	RGS2	5997	upregulated	Silicon Dioxide analog results in increased expression of RGS2 mRNA	1q31.2	A24195
Silicon dioxide	Approved	RGS20	8601	upregulated	Silicon Dioxide analog results in increased expression of RGS20 mRNA	8q11.23	A24195
Silicon dioxide	Approved	RGS20	8601	upregulated	Silicon Dioxide results in increased expression of RGS20 mRNA	8q11.23	A24196
Silicon dioxide	Approved	RGS3	5998	upregulated	Silicon Dioxide analog results in increased expression of RGS3 mRNA	9q32	A24195
Silicon dioxide	Approved	RGS3	5998	downregulated	Silicon Dioxide results in decreased expression of RGS3 mRNA	9q32	A24196
Silicon dioxide	Approved	RGS5	8490	downregulated	Silicon Dioxide analog results in decreased expression of RGS5 mRNA	1q23.3	A24194 A24195
Silicon dioxide	Approved	RGS7	6000	downregulated	Silicon Dioxide analog results in decreased expression of RGS7 mRNA	1q43	A24194

Displaying entries 72576 - 72600 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability